Corrado Blandizzi

Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa; Unit of Adverse Drug Reactions Monitoring, University Hospital of Pisa, Pisa, Italy, Italy

Companies (Contracted Research, He was involved as investigators of observational studies funded by pharmaceutical companies (e.g Galapagos) in compliance with the ENCEPP code of conduct)

Poster(s):

• (P-054) Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases

• (P-059) Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy

• (P-085) Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
  Tuesday, August 24, 2021

  3:30 PM - 4:45 PM US Eastern Time

• (P-086) Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)

• (P-409) Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study